To explore the molecular targets of miR‐637 that may convey its control of multiple malignant phenotypes in glioma cells, we found that miR‐637 mimics were sufficient to reduce SOX10 expression, whereas miR‐637 inhibitor did the opposite on both mRNA (Fig. 9A,B) and protein (Fig. 9C,D) levels. This evidence concerns the gene SOX10 and central nervous system cancer.